Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials-Reference-Cited by-同舟云学术

Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials

Published:2023-07-06 Issue:9 Volume:24 Page:1199-1212
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Maughan Benjamin L.^ORCID,Sirohi Deepika

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11864-023-01107-x.pdf

Reference60 articles.

1. Valenca LB, Hirsch MS, Choueiri TK, Harshman LC. Non-clear cell renal cell carcinoma, part 1: histology. Clin Adv Hematol Oncol. 2015;13(5):308–13.

2. •• Pal SK, Tangen C, Thompson IM, Jr., Balzer-Haas N, George DJ, Heng DYC, et al. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Lancet. 2021;397(10275):695-703. This ransomized clinical trial establishes cabozantinib as the current standard of care for PRCC.

3. Armstrong AJ, Halabi S, Eisen T, Broderick S, Stadler WM, Jones RJ, et al. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Lancet Oncol. 2016;17(3):378–88.

4. Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, et al. Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial. Eur Urol. 2016;69(5):866–74.

5. Courthod G, Tucci M, Di Maio M, Scagliotti GV. Papillary renal cell carcinoma: a review of the current therapeutic landscape. Crit Rev Oncol Hematol. 2015;96(1):100–12.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional Therapies in Immunologically “Cold” Tumors: Opportunities and Clinical Trial Design Considerations;Journal of Vascular and Interventional Radiology;2024-02

2. IL20RB Is a Prognostically Significant Gene and a Potential Biomarker in Papillary Renal Cell Carcinoma;2024